Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Waldenstrôm's macroglobulinemia. Developmental and prognostic study].

P Debre, R Zittoun, M Cadiou

    La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris
    |December 9, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Pentasomy 13q in a case of acute myelogenous leukemia (Mo).

    Cancer genetics and cytogenetics·1998
    Same author

    [Intravascular malignant B-cell lymphomatosis with renal glomerular involvement: a case].

    Nephrologie·1998
    Same author

    Adult biphenotypic acute leukaemia: an entity with poor prognosis which is related to unfavourable cytogenetics and P-glycoprotein over-expression.

    British journal of haematology·1998
    Same author

    Prognostic factors in elderly acute lymphoblastic leukaemia.

    British journal of haematology·1997
    Same author

    Multidrug resistance gene expression in acute myeloid leukemia: major prognosis significance for in vivo drug resistance to induction treatment.

    Annals of hematology·1997
    Same author

    [Neoplastic pulmonary embolism. An uncommon cause of acute respiratory distress with normal pulmonary radiography].

    Revue de pneumologie clinique·1997
    See all related articles

    This study observed 27 Waldenström's macroglobulinemia cases, finding therapy improved outcomes for many. Good prognosis indicators include higher initial hemoglobin and reduced lymphocyte counts after chemotherapy.

    Area of Science:

    • Hematology
    • Oncology
    • Clinical Medicine

    Context:

    • Waldenström's macroglobulinemia (WM) is a rare lymphoproliferative disorder.
    • Observational studies are crucial for understanding WM progression and treatment efficacy.
    • Long-term data on WM patient outcomes are essential for clinical decision-making.

    Purpose:

    • To analyze the clinical course and outcomes of Waldenström's macroglobulinemia patients.
    • To identify prognostic factors influencing patient survival and response to therapy.
    • To document common complications associated with WM.

    Summary:

    • The study followed 27 WM patients for at least two years or until death.
    • Half of the patients experienced disease worsening, with 7 deaths within two years.

    Related Experiment Videos

  • Therapy led to improvement in 10 patients, with only two subsequent deaths. Common complications included infections, hemorrhage, neurological, bone, and kidney issues.
  • Initial hemoglobin levels above 9 g/dL and a significant post-chemotherapy decrease in lymphocyte count were associated with a better prognosis.

    • Impact:

    • Provides insights into the natural history and therapeutic responses in Waldenström's macroglobulinemia.
    • Highlights key prognostic indicators for improved patient management and risk stratification.
    • Informs clinical practice regarding monitoring and treatment strategies for WM.